Kura Oncology is taking technology originally developed around cancer biology into the enormous diabetes market, launching a new company called Caspian Therapeutics with $50 million in financing to investigate whether menin inhibitors…
Grail’s ambitious effort to transform cancer screening is approaching a pivotal regulatory moment. The U.S. Food and Drug Administration has scheduled an advisory committee meeting for September 23, 2026, to evaluate the…
Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human…
Families in Ladera Ranch, an affluent suburban community in southern California, are demanding an urgent investigation after six local children were diagnosed with Ewing sarcoma, an exceptionally rare cancer affecting bones and…
